EUCTR2018-001625-96-BE进行中（未招募）1 期
The effect of hydroxychloroquine sulphate on hedonic food intake, appetite-related sensations and gastrointestinal hormone release in overweight female subject
Z Leuven0 个研究点目标入组 40 人开始时间: 2019年1月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Subject is female between 18 and 65 years of age.
- •Subject has a BMI between 25 and 30 kg/m² and has a stable body weight for at least 3 consecutive months at the start of the study and keeps a stable weight during the study visits.
- •Women of child-bearing potential agree to apply during the entire duration of the trial a highly effective method of birth control, which is defined as those which result in a low failure rate (i.e., less than 1% per year) when used constantly and correctly such as implants, injectables, combined oral contraceptive method, or some intrauterine devices (IUDs), sexual abstinence, or vasectomized partner. Women of non-childbearing potential may be included if surgically sterile (tubal ligation or hysterectomy) or postmenopausal with at least 2 year without spontaneous menses.
- •Subject understands the study procedures and agrees to participate in the study by giving written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subject is under age of legal consent, male, pregnant or breastfeeding.
- •Subject with a BMI = 25 kg/m² or BMI = 30 kg/m².
- •Subject is on a diet to induce weight loss or any other treatment for obesity.
- •Subject has current symptoms or a history of gastrointestinal or other significant somatic or psychiatric diseases or drug allergies.
- •Subject has diabetes.
- •Subject has a significant heart, lung, liver or kidney disease.
- •Subject has any history of a neurological disorder.
- •Subject has a history of abdominal surgery. Those having undergone a simple appendectomy more than 1 year prior to the screening visit may participate.
- •Subject has retinopathy .
- •Subject suffers from psoriasis.
- •Subject has porphyria.
- •Subject shows abnormal eating behavior or has an eating disorder.
- •History or current use of drugs that can affect glycaemia, gastrointestinal function, motility or sensitivity or gastric acidity.
- •History or current use of centrally acting medication, including antidepressants, antipsychotics and/or benzodiazepines (in the last year before screening visit).
- •Subject consumes excessive amounts of alcohol, defined as >14 units per week for women and >21 units per week for men.
- •Subject is currently (defined as within approximately 1 year of the screening visit) a regular or irregular user (including recreational use) of any illicit drugs (including marijuana) or has a history of drug (including alcohol) abuse. Further, patient is unwilling to refrain from the use of drugs during this study.
- •High caffeine intake (> 500 ml coffee daily or equivalent).
- •Inability or unwillingness to perform all of the study procedures, or the subject is considered unsuitable in any way by the principal investigator.
- •Recent participation (<30 days) or simultaneous participation in another clinical study.
- •Subjects with lactose intolerance.
- •Subjects with quinine allergy.
研究者
相似试验
进行中（未招募）
1 期
The effect of a bitter compound on hedonic food intake, appetite-related sensations and gastrointestinal hormone release in healthy female subjectsThe study is meant to have a better understanding in obesity and how we can prevent/cure it. Therefore, the product will first be tested in healthy, lean volunteers.MedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2018-003083-30-BEZ Leuven10
Unknown
4 期
Effect of Hydroxychloroquine Sulphate in Healthy Lean FemalesObesityNCT04005768Universitaire Ziekenhuizen KU Leuven10
已完成
不适用
Effect of hydroxychloroquine on recurrent abortion treatmentrecurrent abortion.Spontaneous abortionIRCT2015120910664N2Experimental Medicine Research Centerof Tehran University of Medical Science,Vice chancellor for res60
Unknown
4 期
Effect of Bitter in Overweight Female VolunteersObesityNCT04005781Universitaire Ziekenhuizen KU Leuven40
已完成
3 期
The prophylactic effect of Hydroxychloroquine on Novel Corona virusIRCT20151222025660N2Arak University of Medical Sciences90